IDBS unveils IDBS Polar Control: Revolutionizing process management in biopharmaceutical development
Polar Control is set to redefine how biopharmaceutical companies manage and evolve their processes
7 Mar 2025
IDBS, a Danaher company, has launched its IDBS Polar Control, a groundbreaking module within the Polar platform designed to transform process management in biopharmaceutical development. The official launch will occur at two prestigious events: the Lab of the Future Congress in Boston and the Biologics Manufacturing Asia (BMA) pre-conference seminar in Singapore.
Polar Control is set to redefine how biopharmaceutical companies manage and evolve their processes. This innovative module enables users to create and manage detailed versions of their individual parameters, and broader process definitions, assigning and monitoring parameter criticality and specifications.
By categorizing the criticality of individual parameters, maintaining a comprehensive version history, and establishing connectivity with experiments and results, Polar Control provides unparalleled insight into the evolution of processes over time.
Key features of Polar Control include:
- Granular parameter management: Track and manage individual process parameters with precision, ensuring optimal conditions are maintained throughout development.
- Comprehensive version history: Maintain a detailed history of changes to process parameters, allowing for better understanding and control over process evolution.
- Enhanced process understanding: By accurately recording process data, Polar Control helps reduce future study time and improve process efficiency.
- Facilitated technology transfer: The module streamlines technology transfer by offering a clear and detailed record of process parameters and their evolution, making it easier to replicate and transfer processes between teams and facilities with accurate process knowledge.
The launch of Polar Control is part of IDBS’ ongoing commitment to providing cutting-edge solutions that drive digital maturity in the biopharmaceutical Industry. With this new module, IDBS aims to support late-stage development and CDMO organizations, as well as prospects transitioning from non-GxP to GxP environments.
“Polar Control addresses a significant gap in digital process management,” said Pietro Forgione, General Manager at IDBS. “Our solution offers a centralized knowledge repository for parameter tracking, seamlessly connecting to process execution. This not only accelerates drug development and technology transfer but also reduces the need for repetitive experiments, ultimately speeding up time to market.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Links
Tags
Frequently asked questions
Show frequently asked questions
What is IDBS Polar Control for biopharmaceutical process management?
IDBS Polar Control is a module within the Polar platform that centralizes process knowledge. It enables biopharmaceutical companies to manage parameter versions, criticality, specifications, experiments, and results while tracking how process definitions evolve over time.
How does Polar Control support drug development and technology transfer?
Polar Control connects parameter tracking with process execution, helping accelerate drug development and technology transfer. Its detailed records make processes easier to replicate across teams and facilities, reduce repetitive experiments, improve efficiency, and potentially shorten time to market.
Which organizations can benefit from IDBS Polar Control?
IDBS designed Polar Control to support late-stage biopharmaceutical development, contract development and manufacturing organizations (CDMOs), and organizations transitioning from non-GxP to GxP environments. The module promotes digital maturity through granular parameter management, comprehensive version histories, and enhanced process understanding.
